We tested the ability of a constitutively activated erythropoietin receptor [EpoR(R129C) 
abrogated the Epo requirement oferythroid colony-foming units to form erythrocytes after 2-5 days in culture and did not interfere with the differentiation program of these cells. In the absence of added growth factors EpoR(R129C) did not enhance erythroid burst-forming unit development. In contrast to experiments in heterologous cell lines, EpoR(R129C) did not render progenitor cells independent of interleukin 3 or granulocyte/macrophage colony-stimulating factor (GM-CSF). However, when progenitors were cultured with added steel factor, but not with interleuidn 3 or GM-CSF, EpoR(R129C) au n the growth and differentiation of erythroid bursts, mixd erythroid/myeloid, and granulocyte/macrophage (GM) colonies.
Furthermore, both viruses were capable of expressing EpoR(R129C) in erythroid, mixed erythroid/myeloid, and GM colonies. Thus an aberrantly expressed and constitutively activated EpoR can stimulate proliferation of some GM progenitors.
The ability of EpoR(R129C) to abrogate the Epo requirement of primary hematopoletic cells, but not the requirement for other cytokines, is consistent with the induction of erythroblastosis in vivo.
The precise role of hematopoietic growth factors in hematopoiesis has not been established, but they can affect cellular viability, differentiation, proliferation, and end stage function (1) (2) (3) . These regulatory molecules influence their target cells through interaction with ligand-specific receptors on the cell surface. The receptors for erythropoietin (Epo), interleukins 2-7 (IL-2, IL-3, IL-4, IL-5, IL-6, IL-7), granulocyte/macrophage colony-stimulating factor (GM-CSF), and G-CSF define a new hematopoietin receptor superfamily (4, 5) . These type 1 membrane proteins share common structural features within their extracellular domains yet have divergent cytoplasmic domains that lack any known signal transducing motifs; the mode(s) of signal transduction remains largely unknown. Expression in heterologous cell lines of cDNAs encoding members of the hematopoietin receptor superfamily has fostered the notion that some share aspects of common signaling pathways. For example, expression of the Epo receptor (EpoR) in IL-3-dependent cell lines (6, 7) allows these cells to proliferate in medium containing added Epo. Whether or not the EpoR can supplant the IL-3 receptor or other cytokine receptors during hematopoiesis is not known.
A point mutation in the extracellular domain (R129C) ofthe EpoR generates a receptor, EpoR(R129C), that confers growth factor-independent proliferation upon certain hematopoietic cell lines (8, 9) . Mice infected with a recombinant spleen focus-forming virus (SFFV) expressing EpoR(R129C) (SFFVcEpoR) develop erythrocytosis, and growth factorindependent erythroleukemic cell lines can be isolated from the spleen of infected mice (9, 10) . In these infected mice unregulated proliferation of erythroid progenitors predominates. This erythroid restriction may be the result of a transcriptional restriction imposed upon EpoR(R129C) by the SFFV long terminal repeats (LTRs) (11) (12) (13) or the inability of EpoR(R129C) to function in cells other than erythrocyte progenitors.
Here we tested the capabilities of EpoR(R129C) to alter the growth requirements of primary fetal liver hematopoietic precursors that terminally differentiate in culture. EpoR(R129C) completely abrogated the Epo requirement for erythroid colony-forming units (CFU-E) to form erythrocytes after 2-5 days in culture and did not interfere with the differentiation program of these cells. In the absence of added growth factors EpoR(R129C) did not enhance erythroid burstforming unit (BFU-E) development or result in other progenitor cell growth. However, when progenitors were cultured with added steel factor (SF), but not with IL-3 or GM-CSF, EpoR(R129C) augmented the growth and differentiation of BFU-E, mixed erythroid/myeloid, and some granulocyte/ (8) . The ends were blunted, Bcl I linkers were ligated to the ends, and the fragments were ligated into the Bcl I site of plasmid pGD' (14) . The resultant plasmids pMPSVEpoR and pMPSVcEpoR ( Fig. 1) were transfected into the retroviral packaging cell lines q/CRE and iCRIP (15) and G418-resistant pools of each packaging cell line were isolated. High-titer viruses were generated by mixing the two G418-resistant pools. The resultant viruses were termed MPSVEpoR and MPSVcEpoR.
Cell Lines. The Epo-dependent erythroleukemic cell line HCD57 (16) was maintained in Iscove's modified Dulbecco's essential medium supplemented with 20%o heat-inactivated fetal calf serum and 0.5 unit of Epo per ml. Factorindependent HCD57cEpoR cells were generated by infecting HCD57 cells with the SFFVcEpoR virus (9) . qiCRE and ,lrCRIP cells were maintained in Dulbecco's modified essential medium containing 10% heat-inactivated calf serum.
Infection and Culture of Hematopoietic Progenitor Cells. Single cell suspensions of fetal livers were prepared from day 13 pregnant BALB/c mice (Charles River Breeding Laboratories). Cells were washed three times in a-medium. Cells (106) were resuspended in medium containing fresh or frozen virus, and 4 ,ug of Polybrene per ml was added; cells were then kept on ice for 2.5 hr. Following infection, samples were washed in a-medium and replated in a-medium containing 30% fetal bovine serum (Sterile Systems, Logan, UT), 1% crystallized bovine serum albumin (Sigma), 1.2% 1500-cP (1 P = 0.1 Pa-sec) methylcellulose (Fisher Scientific), and 50 ,uM 2-mercaptoethanol (Sigma) at a cell concentration of 105 per ml unless otherwise specified. Mouse SF was provided by Steven Clark (Genetics Institute, Cambridge, MA) (17) . Recombinant mouse IL-3 was a gift from Tetsuo Sudo (Biomaterial Research Institute, Yokohama, Japan). Partially purified human urinary Epo, specific activity = 250 units/mg, was a generous gift from M. Kawakita (Kumamoto University, Japan).
RNA PCR. RNA was extracted by a modification of the guanidine isothiocyanate/acid/phenol method described by Chomczynski and Sacchi (18) . cDNA synthesis was carried out with random hexamer primers and Superscript reverse transcriptase (BRL). cDNA from individual colonies was prepared by a modification of the method described by Iscove and coworkers. (19) . PCR was carried out with AmpliTaq (Perkin-Elmer/Cetus) using a DNA thermocycler (Perkin-Elmer/Cetus) under reaction conditions recommended by Cetus. Fifty cycles were used: 1 min at 94°C, 2 min at 55°C, and 4 min at 72°C. The primers were as follows ( (23) . Blots were washed in 6x SSPE, three times for 15 in at room temperature and once for 15 min at 58°C, and then exposed by autoradiography.
RESULTS
To understand the role of signals transduced by the EpoR in hematopoiesis, a constitutively activated EpoR was introduced into hematopoietic progenitor cells by infecting fetal liver cells with two high-titer retroviruses expressing EpoR(R129C). In the absence of any added hematopoietic growth factor, only committed erythroid progenitors were stimulated to proliferate and differentiate (Table 1) . Epoindependent erythroid colonies were observed between days 2 and 5 of culture, indicating that these resulted from CFU-E proliferation and differentiation, normally dependent on added Epo. The abrogation of Epo dependency for CFU-E growth following infection was complete and maximal, in that no significant increase in erythroid colony development occurred with the addition of Epo to EpoR(R129C)-infected cultures, as compared to uninfected or wild-type EpoRinfected cultures with added Epo (Table 1, experiment A). All colonies contained hemoglobinized cells, implying that there was no arrest in the erythroid differentiation program ofthese infected CFU-E (data not shown). SFFVcEpoR and MPSVcEpoR had the same stimulatory effect ( Table 1) . Introduction of the wild-type EpoR gene into progenitor cells had no effect upon erythroid colony growth in the absence ofadded growth Cell Biology: Pharr et (Fig. 2A) but not IL-3 (Fig.  2D) or GM-CSF (data not shown). The average size of day 7 erythroid burst colonies (BFU-E) in cultures containing SF was 3.5 times larger in infected than in uninfected cultures. In addition, EpoR(R129C) in the presence of SF, but not of IL-3 or GM-CSF, resulted in a slight but significant increase in the number of GM colonies (Fig. 2 C and F , and data not shown). The average size of GM colonies in infected cultures did not differ from those in uninfected cultures grown in SF.
Also, the number of day 7 mixed erythroid/myeloid colonies was increased in SFFVcEpoR-infected cultures, relative to uninfected cells, in the presence of SF (Fig. 2B) but not in the presence of IL-3 (Fig. 2E) (24) (25) (26) (27) (28) (29) . After these progenitors become committed to a particular lineage, they require specific growth factors to complete the maturation process; for example, BFU-E and CFU-E require Epo to complete erythroid differentiation (30, 31) . In the absence of Epo, proerythroblasts undergo apoptosis (2) . The effects of Epo are restricted to the early erythroid, and possibly megakaryocytic cell lineages, and occur relatively late in the development of these cell types (30) (31) (32) . This restricted cellular activity of Epo is thought to be, in part, modulated by the regulated expression ofthe gene encoding the cell-surface Epo receptor (33) .
Here hematopoietic progenitors in fetal liver were infected with retroviruses expressing a constitutively activated EpoR. Epo-independent erythroid colonies were observed between days 2 and 5, consistent with differentiation of a population of cells, CFU-E, normally maximally sensitive to Epo (34, 35) The effect of EpoR(R129C) expression on proliferation of GM progenitors and BFU-E was much less than on CFU-E proliferation: a 2.5-to 3-fold vs. a 10-fold stimulation, respectively. The reduced proliferative effect on EpoR(R129C) on BFU-E and CFU-GM was not the result of differing rates of infection or expression in the different colonies. Perhaps BFU-E and CFU-GM are relatively less responsive to the EpoR(R129C) than are CFU-E cells.
SF plus insulin and insulin-like growth factor I are capable of supporting the growth of highly purified human BFU-E in serum-free cultures, whereas IL-3 alone is not (36) . Similarly, we observed a synergistic effect on SF and EpoR(R129C), but not IL-3 or GM-CSF, upon BFU-E proliferation and differentiation. IL-3 was, however, capable of supporting GM colonies in fetal liver cultures. One explanation for the observed cooperativity between the SF-c-kit and Epo-EpoR signal transducing pathways is that SF may expand an early Epo-unresponsive population of cells (37, 38) . Alternatively, the interaction of SF with its receptor, c-kit, may directly or indirectly activate the EpoR, resulting in "priming" of the cells to Epo responsiveness (38) .
The present results indicate that EpoR(R129C) is capable of transducing a growth signal in some nonerythroid, hematopoietic, cells. That the proliferative effects of EpoR-(R129C) on nonerythroid cells are less than on erythroid progenitors may explain the predominant erythrocytosis ob- Single colonies were picked from virally infected cultures grown in the presence of 5 units of SF per ml. cDNA were generated, and PCR was performed using primers 1 and 2 for cEpoR-SFFV-infected colonies, and primers 5 and 4 were used for cEpoR-MPSV-infected colonies. The PCR product was blotted onto nylon membranes and probed with an EpoR oligonucleotide. served in the early stages of SFFVcEpoR infection ofmice (9, 10) . The results obtained from the culture of primary cells agree with in vivo studies in that the predominant effect of EpoR(R129C) was the abrogation of the Epo requirement of erythroid progenitors (9, 10) . The nature of the EpoR(R129C) intracellular signal is unknown. However, protein-tryosine phosphorylation is increased after Epo addition to erythroid and nonerythroid hematopoietic cell lines containing an EpoR (7, 39, 40) . Similarly EpoR(R129C) might activate a protein kinase common to some myeloid and erythroid progenitors.
